Stock Market News1 month CHMP Endorses Merck’s Kidney Cancer Drug for Two Indications Zacks
The CHMP’s opinion is based on positive results from two late-stage studies on MRK’s Welireg in two indications associated with renal cell carcinoma.
XThe CHMP’s opinion is based on positive results from two late-stage studies on MRK’s Welireg in two indications associated with renal cell carcinoma.
X